BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 7519210)

  • 1. B lymphocytes of mice display an aberrant activation phenotype and are cell cycle arrested in G0/G1A during acute infection with Trypanosoma brucei.
    Sacco RE; Hagen M; Donelson JE; Lynch RG
    J Immunol; 1994 Aug; 153(4):1714-23. PubMed ID: 7519210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of B cell responses to the variant surface glycoprotein molecule in trypanosomiasis. II. Down-regulation of idiotype expression is associated with the appearance of lymphocytes expressing antiidiotypic receptors.
    Theodos CM; Mansfield JM
    J Immunol; 1990 May; 144(10):4022-9. PubMed ID: 1970594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Trypanosoma brucei bloodstream form mutant deficient in ornithine decarboxylase can protect against wild-type infection in mice.
    Mutomba MC; Li F; Gottesdiener KM; Wang CC
    Exp Parasitol; 1999 Feb; 91(2):176-84. PubMed ID: 9990346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes.
    Berg DJ; Lynch RG
    J Immunol; 1991 Apr; 146(8):2865-72. PubMed ID: 1826699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosomal surface coat variant antigen causes polyclonal lymphocyte activation.
    Diffley P
    J Immunol; 1983 Oct; 131(4):1983-6. PubMed ID: 6604754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative versus classical macrophage activation during experimental African trypanosomosis.
    Namangala B; De Baetselier P; Noël W; Brys L; Beschin A
    J Leukoc Biol; 2001 Mar; 69(3):387-96. PubMed ID: 11261785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle.
    Sztein MB; Kierszenbaum F
    Immunology; 1991 Jun; 73(2):180-5. PubMed ID: 2071163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice.
    Muul LM; Scher I; Mond JJ; Finkelman FD
    J Immunol; 1983 Nov; 131(5):2226-31. PubMed ID: 6605378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine T lymphocyte specificity for African trypanosomes. I. Induction of a T lymphocyte-dependent proliferative response to Trypanosoma brucei.
    Gasbarre LC; Hug K; Louis JA
    Clin Exp Immunol; 1980 Jul; 41(1):97-106. PubMed ID: 6160003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the host immune response in the development of tissue lesions associated with African trypanosomiasis in mice.
    Galvao-Castro B; Hochmann A; Lambert PH
    Clin Exp Immunol; 1978 Jul; 33(1):12-24. PubMed ID: 309369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional depletion of T- and B-memory cells and other lymphoid cell subpopulations-during trypanosomiasis.
    Askonas BA; Corsini AC; Clayton CE; Ogilvie BM
    Immunology; 1979 Feb; 36(2):313-21. PubMed ID: 155650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4.
    Bakhiet M; Jansson L; Büscher P; Holmdahl R; Kristensson K; Olsson T
    J Immunol; 1996 Oct; 157(8):3518-26. PubMed ID: 8871651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor cells in mice infected with Trypanosoma brucei.
    Eardley DD; Jayawardena AN
    J Immunol; 1977 Sep; 119(3):1029-33. PubMed ID: 302268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of IL-2 hyper-responsive NZB/WF1 CD5- B cells.
    Hirose S; Nakanishi K; Yoshimoto T; Kashiwamura S; Hiroishi K; Matsumoto H; Hamaoka T; Shinka S; Higashino K
    J Immunol; 1994 Aug; 153(4):1847-57. PubMed ID: 7519217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of T helper cell responses to the trypanosome variant surface glycoprotein.
    Schleifer KW; Filutowicz H; Schopf LR; Mansfield JM
    J Immunol; 1993 Apr; 150(7):2910-9. PubMed ID: 8454863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
    Kierszenbaum F; Moretti E; Sztein MB
    Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine T lymphocyte specificity for African trypanosomes. II. Suppression of the T lymphocyte proliferative response to Trypanosoma brucei by systemic trypanosome infection.
    Gasbarre LC; Hug K; Louis J
    Clin Exp Immunol; 1981 Jul; 45(1):165-72. PubMed ID: 6458434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent regulation of B cell responses to surface and subsurface epitopes of African trypanosome variable surface glycoproteins.
    Reinitz DM; Mansfield JM
    J Immunol; 1988 Jul; 141(2):620-6. PubMed ID: 2454998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocyte development and activation independent of MHC class II expression.
    Markowitz JS; Rogers PR; Grusby MJ; Parker DC; Glimcher LH
    J Immunol; 1993 Feb; 150(4):1223-33. PubMed ID: 8432977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
    Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
    J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.